← Leaderboards
Karina Yazdanbakhsh
New York Blood Center
$18,887,767
Attributed
$18,887,767
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,443,770 · 13
By mechanism
P01$23,075,260 · 5
R01$10,336,678 · 6
R35$3,589,657 · 1
R21$442,175 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Blood Center
Same institution · by research overlap
- Xiuli An$8,630,004
- Marion E Reid$2,570,638
- Hui Zhong$1,617,308
- Shan Su$427,000
Others in their field
Top investigators on “Transfusion”
- Russell E Ware · Duke University$40,659,016
- Susan Fera Assmann · New England Research Institutes, Inc.$32,364,291
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$30,236,292
- Gabriel Muyinda · Zambia National Blood Transfusion Srv$23,779,270
- Michael Rutledge Debaun · Vanderbilt University Medical Center$23,544,275
- Abhik Das · Research Triangle Institute$22,986,828
Research focus
TransfusionCellsImmuneAffectChronicImmune ResponseSickle Cell AnemiaInflammatoryHemolysisResponseLifeAlloimmunizationIn VitroPreventMolecularHemeT-LymphocyteB-LymphocytesReportingInsightFunctional DisorderMediatingIsoantibodiesPathway Interactions
Grant awards (48)
Complications of Hemolysis and Transfusion Therapy$3,043,095
P01 · FY2025 · HL · contact PI
Immune Pathophysiology of Sickle Cell Disease$920,420
R35 · FY2025 · HL · contact PI
Alloimmunization and Humoral Immune Response to Hemolysis and EPO$606,340
P01 · FY2025 · HL · contact PI
Administrative Core$170,800
P01 · FY2025 · HL · contact PI
Complications of Hemolysis and Transfusion Therapy$3,041,589
P01 · FY2024 · HL · contact PI
Immune Pathophysiology of Sickle Cell Disease$902,011
R35 · FY2024 · HL · contact PI
Alloimmunization and Humoral Response to Hemolysis$599,952
P01 · FY2024 · HL · contact PI
Admin Core$115,433
P01 · FY2024 · HL · contact PI
Complications of Hemolysis and Transfusion Therapy$3,103,662
P01 · FY2023 · HL · contact PI
Immune Pathophysiology of Sickle Cell Disease$920,420
R35 · FY2023 · HL · contact PI
Alloimmunization and Humoral Response to Hemolysis$612,195
P01 · FY2023 · HL · contact PI
Admin Core$117,788
P01 · FY2023 · HL · contact PI
Complications of Hemolysis and Transfusion Therapy$3,103,662
P01 · FY2022 · HL · contact PI
Immune Pathophysiology of Sickle Cell Disease$846,806
R35 · FY2022 · HL · contact PI
Alloimmunization and Humoral Response to Hemolysis$647,795
P01 · FY2022 · HL · contact PI
Admin Core$117,788
P01 · FY2022 · HL · contact PI
Complications of Hemolysis and Transfusion Therapy$3,121,462
P01 · FY2021 · HL · contact PI
Alloimmunization and Humoral Response to Hemolysis$647,795
P01 · FY2021 · HL · contact PI
Patrolling Monocytes in Sickle Pain Crisis and following Transfusion$445,000
R01 · FY2021 · HL · contact PI
Admin Core$117,788
P01 · FY2021 · HL · contact PI
Complications of Hemolysis and Transfusion Therapy$3,142,533
P01 · FY2020 · HL · contact PI
Alloimmunization and Humoral Response to Hemolysis$647,795
P01 · FY2020 · HL · contact PI
Patrolling Monocytes in Sickle Pain Crisis and following Transfusion$445,000
R01 · FY2020 · HL · contact PI
Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization$426,500
R01 · FY2020 · HL · contact PI
Admin Core$117,788
P01 · FY2020 · HL · contact PI
Patrolling Monocytes in Sickle Pain Crisis and following Transfusion$445,000
R01 · FY2019 · HL · contact PI
Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization$426,500
R01 · FY2019 · HL · contact PI
Immunopathology of ITP$493,812
R01 · FY2018 · HL · contact PI
Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization$426,500
R01 · FY2018 · HL · contact PI
T cell Immunoregulation of alloimmunization in sickle cell disease$617,404
R01 · FY2017 · HL · contact PI
Immunopathology of ITP$493,812
R01 · FY2017 · HL · contact PI
Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization$426,500
R01 · FY2017 · HL · contact PI
T cell Immunoregulation of alloimmunization in sickle cell disease$617,404
R01 · FY2016 · HL · contact PI
Immunopathology of ITP$493,812
R01 · FY2016 · HL · contact PI
Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization$426,500
R01 · FY2016 · HL · contact PI
T cell Immunoregulation of alloimmunization in sickle cell disease$606,459
R01 · FY2015 · HL · contact PI
Immunopathology of ITP$492,102
R01 · FY2015 · HL · contact PI
T cell Immunoregulation of alloimmunization in sickle cell disease$630,879
R01 · FY2014 · HL · contact PI
Immunoregulatory responses in patients with ITP$385,526
R01 · FY2012 · HL · contact PI
Immunoregulatory responses in patients with ITP$389,291
R01 · FY2011 · HL · contact PI
Immunoregulatory responses in patients with ITP$389,164
R01 · FY2010 · HL · contact PI
Transfusion-associated immune hemolysis$200,125
R21 · FY2010 · HL · contact PI
Immunoregulatory responses in patients with ITP$401,233
R01 · FY2009 · HL · contact PI
Transfusion-associated immune hemolysis$242,050
R21 · FY2009 · HL · contact PI
Erythrocyte Complement Receptor 1 in Transfusion/Malaria$217,824
R01 · FY2005 · HL
Erythrocyte Complement Receptor 1 in Transfusion/Malaria$215,848
R01 · FY2004 · HL
Erythrocyte Complement Receptor 1 in Transfusion/Malaria$213,931
R01 · FY2003 · HL
Erythrocyte Complement Receptor 1 in Transfusion/Malaria$210,677
R01 · FY2002 · HL